Antibody-drug conjugates: beyond current approvals and potential future strategies
Author:
Affiliation:
1. Olivia Newton-John Cancer Centre at Austin Health, Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg Victoria 3084, Australia;College of Science, Health and Engineering, La Trobe University, Melbourne Victoria 3086, Australia
Abstract
Publisher
Open Exploration Publishing
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference178 articles.
1. Postel-Vinay S, Soria JC. Phase I trials in oncology: a new era has started. Ann Oncol. 2015;26:7–9.
2. Armitage JD, Newnes HV, McDonnell A, Bosco A, Waithman J. Fine-tuning the tumour microenvironment: current perspectives on the mechanisms of tumour immunosuppression. Cells. 2021;10:56.
3. Duan Q, Zhang H, Zheng J, Zhang L. Turning cold into hot: firing up the tumor microenvironment. Trends Cancer. 2020;6:605–18.
4. Beck A, Reichert JM. Antibody-drug conjugates: present and future. MAbs. 2014;6:15–7.
5. Carter PJ, Senter PD. Antibody-drug conjugates for cancer therapy. Cancer J. 2008;14:154–69.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03);Frontiers in Oncology;2024-01-10
2. Colorectal cancer cell exosome and cytoplasmic membrane for homotypic delivery of therapeutic molecules;International Journal of Pharmaceutics;2023-11
3. Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2;Nuclear Medicine and Biology;2023-07
4. Unlocking the Potential of Bio‐Based Nitrogen‐Rich Furanic Platforms as Biomass Synthons;Angewandte Chemie International Edition;2023-06
5. Unlocking the Potential of Bio‐Based Nitrogen‐Rich Furanic Platforms as Biomass Synthons;Angewandte Chemie;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3